The Legal section explores developments shaping the justice system—from landmark court decisions and legislative updates to consumer protection issues and civil rights cases. Our Legal section coverage helps readers understand how new laws, legal trends, and significant verdicts impact individuals, families, and communities nationwide.
“The only thing we have to fear is fear itself.” Franklin Delano Roosevelt Fear: the greatest tool of manipulators. When you listen to politicians, pundits, or anyone for that matter, and they are telling you to be afraid, the first thing you should do is…
Anyone familiar with the Hippocratic oath understands the undeniable bond between medical care and ethics—ideally, physicians are driven by the desire to help patients, not hurt them. Yet, harm does sometimes occur, and patients have the right to hold such doctors accountable in a court…
Many of the attorneys who use the demonstrative aids created by MediVisuals, or by others, are familiar with the technical aspects associated with “Laying the Foundation” of graphics for “Demonstrative Evidence.”
The Judicial Panel on Multidistrict Litigation consolidated 15 federally filed morcellator cases on Thursday for pre-trial discovery and trial work up. The request for the Morcellator MDL was made by Plaintiffs in an effort to streamline the litigation and fast track the efficient handling of the…
A lawsuit filed last week in state court in Philadelphia, Pennsylvania alleges that Xarelto’s recommended dosage doesn’t work for as long as is represented by the manufacturer, Janssen Pharmaceuticals and Bayer HealthCare. It is believed to be the first in the nation to allege that…
According to a study conducted by researchers for Johns Hopkins Bloomberg School of Public Health and George Washington University that was published on April 24, 2015 in the British Medical Journal, Xarelto may present double warfarin’s risk of serious gastrointestinal bleeds, and Pradaxa may incre
The U.S. Food and Drug Administration (FDA) has rejected three attempts by Johnson & Johnson to expand the approval of its anti-blood clotting drug, Xarelto, according to a report in the Wall Street Journal. Xarelto is approved as a preventative medicine for patients with pulmonary…
On Friday, February 20, 2015, DePuy/ Johnson & Johnson agreed to pay approximately $420 million more to resolve approximately 1400 additional DePuy ASR lawsuits. The order came from the Court extending the settlement offer to Plaintiffs who had revision surgery after August 31, 2013 up…
On December 22, 2014, China officially approved imports of a type of genetically modified corn – Syngenta’s Agrisure Viptera® MR162, ending China’s yearlong ban of imports of all corn containing any trace of the Viptera MR162 trait. The ban had essentially shut U.S. corn out…
Just over two years since the Stryker Rejuvenate and ABGII hip implant products were recalled from the market in June 2012, national leadership in the multi-district litigation (MDL) today announced a global settlement proposal for all Stryker Rejuvenate and ABGII hip implant victims who have…
Nearly 3,000 lawsuits have been filed against Stryker related to their Rejuvenate and ABG II Modular-Neck Stem Hip Implants. Here are some common questions that patients and the general public may have regarding these products: 1) Why were the Stryker Rejuvenate and ABG II Modular-Neck…
The Bombshell from Miami-Dade County Circuit Court is no doubt reverberating throughout the halls of Tallahassee this week and will most certainly dominate discussion at the 69th Annual Workers’ Compensation Educational Conference to be hosted this week by the Workers’ Compensation Institute in Orla
